Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07219706 · ClinicalTrials.gov registry record · NA

Dietary Fiber and Time Restricted Eating

A NA study of Cancer Prevention and Diet Habits, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT07219706: Recruiting NA study of Cancer Prevention and Diet Habits, sponsored by University of Oklahoma.

NCT07219706 is a NA study of Cancer Prevention and Diet Habits that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 90 participants, below the 408-participant average among 6 other Cancer Prevention trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07219706, a NA study of Cancer Prevention and Diet Habits, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This study is seeking to examine combinations of two different dietary interventions on cancer risk.

Primary Outcome

Dietary fiber intake as reported on 3-day diet records and analyzed according to Nutrition Data System for Research; reported as a mean intake over three days in grams per day

Interventions

  • BEHAVIORAL Counseling
  • BEHAVIORAL Time Restricted Eating
  • BEHAVIORAL Group education

Study Locations (1)

Ohio

  • University of Oklahoma Health Sciences - Columbus

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2026-12-10
Est. Completion 2027-06-30
Phase NA
University of Oklahoma

358 total trials

What NCT07219706 shows while recruiting

NCT07219706 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 408-participant average among 6 other Cancer Prevention trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Cancer Prevention appearing as the primary indexed condition, and to 3 interventions - of which Counseling is the first listed.

NCT07219706 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07219706 about?

NCT07219706 is a clinical study titled "Dietary Fiber and Time Restricted Eating". This study is seeking to examine combinations of two different dietary interventions on cancer risk.

What is the current status of trial NCT07219706?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-12-10. Estimated completion is 2027-06-30.

What conditions does trial NCT07219706 study?

This clinical trial studies the following conditions: Cancer Prevention, Diet Habits.

What interventions are being tested in trial NCT07219706?

The interventions under investigation include: Counseling (BEHAVIORAL), Time Restricted Eating (BEHAVIORAL), Group education (BEHAVIORAL).

Who is sponsoring clinical trial NCT07219706?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07219706 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07219706, the US trial registry maintained by the National Library of Medicine. NCT07219706 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.